Yonkers, N.Y.
ContraFect will begin construction in early 2011 on a 15,000-sf headquarters and R&D facility in Yonkers, N.Y. The project will provide biotechnology research laboratories for the creation of advanced therapies from monoclonal antibodies and lysins. A second phase of construction could include 45,000 sf of research space and a pilot plant.
